Robert J. Terifay, SVP Commercial at REGENERON PHARMACEUTICALS INC (REGN), sold 48,750 shares at $401.42 ($19.7M) on 2014-11-18, disclosed to the SEC on 2014-11-19.
Scheduled sale ($19.7M) by SVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $401.75 | 2,578 | $1.0M | 5.3% |
| 2 | $401.75 | 23,810 | $9.6M | 48.6% |
| 3 | $400.45 | 62 | $25K | 0.1% |
| 4 | $401.42 | 400 | $161K | 0.8% |
| 5 | $402.71 | 1,500 | $604K | 3.1% |
| 6 | $403.86 | 2,150 |
| $868K |
| 4.4% |
| 7 | $404.75 | 3,252 | $1.3M | 6.7% |
| 8 | $405.85 | 7,278 | $3.0M | 15.0% |
| 9 | $406.89 | 3,720 | $1.5M | 7.7% |
| 10 | $407.85 | 2,200 | $897K | 4.6% |
| 11 | $408.62 | 1,800 | $736K | 3.7% |
| Total | $403.60 avg | 48,750 | $19.7M | 100% |
| Filing → |
| REGN | SELL | 2015-03-18 | $5.0M | — | Filing → |
| REGN | SELL | 2015-02-25 | $4.7M | — | Filing → |
| REGN | SELL | 2014-02-19 | $4.3M | — | Filing → |